Valuation: Danaher Corporation

Market Cap 14TCr 13TCr 12TCr 11TCr 20TCr 13,79800Cr 20TCr 1,38100Cr 54TCr 6,90900Cr 54TCr 53TCr 23,03800Cr P/E 2026 *
34.5x
P/E 2027 * 28.3x
Enterprise Value 16TCr 14TCr 13TCr 12TCr 23TCr 15,71200Cr 23TCr 1,57300Cr 61TCr 7,86700Cr 62TCr 61TCr 26,23300Cr EV / Sales 2026 *
6.25x
EV / Sales 2027 * 5.59x
Free-Float
70.46%
Yield 2026 *
0.71%
Yield 2027 * 0.76%
1 day-0.80%
1 week+3.07%
Current month+5.54%
1 month+3.39%
3 months+23.78%
6 months-4.26%
Current year-10.10%
1 week 198.44
Extreme 198.435
209.37
1 month 165.75
Extreme 165.75
209.9
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap.
04/08/26 Free

Chief Technology Officer

13,477 0.0019%
04/08/26 Free

Executive/Senior Manager

2,45,701 0.0350%
04/08/26 Free

Founder

15,00,000 0.2134%
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%+3.07%+0.03%-19.43% 14TCr
-0.33%+4.36%+26.31%+10.89% 22TCr
+0.01%+6.95%-16.09%+31.78% 14TCr
+0.45%+7.71%-49.90%+0.76% 7.45TCr
-0.65%+4.59%+20.95%+17.18% 5.36TCr
-1.41%-0.54%-15.65%-17.29% 5.01TCr
-0.84%+5.05%+26.36%+16.85% 4.19TCr
+0.28%+4.04%+45.75%+42.68% 4.09TCr
-0.65%+2.90%-2.86%+0.96% 3.26TCr
+0.52%+0.88%-20.22%+25.93% 3.26TCr
Average -0.18%+3.90%+1.47%+11.03% 8.36TCr
Weighted average by Cap. -0.24%+4.42%+2.91%+9.05%

Financials

2026 *2027 *
Net sales 2.63TCr 2.28TCr 2.14TCr 1.95TCr 3.67TCr 2,51300Cr 3.72TCr 25TCr 9.83TCr 1,25800Cr 9.89TCr 9.68TCr 4,19500Cr 2.85TCr 2.47TCr 2.31TCr 2.11TCr 3.96TCr 2,71500Cr 4.02TCr 27TCr 11TCr 1,35900Cr 11TCr 10TCr 4,53300Cr
Net income 424.1Cr 367.44Cr 344.27Cr 314.01Cr 590.36Cr 40TCr 599.43Cr 4.05TCr 1.58TCr 20TCr 1.59TCr 1.56TCr 68TCr 518.53Cr 449.26Cr 420.93Cr 383.93Cr 721.8Cr 49TCr 732.9Cr 4.95TCr 1.94TCr 25TCr 1.95TCr 1.9TCr 83TCr
Net Debt 2.01TCr 1.74TCr 1.63TCr 1.49TCr 2.79TCr 1,91400Cr 2.84TCr 19TCr 7.49TCr 96TCr 7.53TCr 7.37TCr 3,19500Cr 1.45TCr 1.26TCr 1.18TCr 1.08TCr 2.02TCr 1,38700Cr 2.06TCr 14TCr 5.43TCr 69TCr 5.46TCr 5.34TCr 2,31600Cr
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
12/26/12 $205.79 -0.80% 30,38,429
11/26/11 $207.44 -0.92% 24,72,738
10/26/10 $209.37 +2.25% 36,78,061
07/26/07 $204.76 +2.39% 33,23,842
06/26/06 $199.98 +0.16% 27,93,691
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
205.79USD
Average target price
227.96USD
Spread / Average Target
+10.77%

Quarterly revenue - Rate of surprise